KNIGHT THERAPEUTICS
Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets. Knight Therapeutics' shares began trading on the TSX-V on March 3, 2014 under the symbol GUD.
KNIGHT THERAPEUTICS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1995-01-01
Address:
Westmount, Quebec, Canada
Country:
Canada
Website Url:
http://www.gud-knight.com
Total Employee:
101+
Status:
Active
Contact:
(514) 484-4483
Email Addresses:
[email protected]
Total Funding:
490.01 M USD
Technology used in webpage:
SPF LetsEncrypt Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS GoDaddy DNS Google Maps API Imperva Bot Detection And Mitigation Incapsula
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-10-21 | Grupo Biotoscana SL | Grupo Biotoscana SL acquired by Knight Therapeutics | 281 M USD |
Investors List
Long Zone Holdings
Long Zone Holdings investment in Post-IPO Equity - Knight Therapeutics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-08-10 | Synergy CHC | Knight Therapeutics investment in Post-IPO Debt - Synergy CHC | 10 M USD |
| 2016-01-25 | INTEGA Skin Sciences | Knight Therapeutics investment in Debt Financing - INTEGA Skin Sciences | 12.3 M CAD |
| 2015-08-26 | Advaxis | Knight Therapeutics investment in Post-IPO Equity - Advaxis | 25 M USD |
| 2015-04-30 | Profound Medical Inc | Knight Therapeutics investment in Venture Round - Profound Medical Inc | 28 M CAD |
Official Site Inspections
http://www.gud-knight.com Semrush global rank: 5.72 M Semrush visits lastest month: 1.47 K
- Host name: edge.redirect.pizza
- IP address: 89.106.200.1
- Location: Luxembourg
- Latitude: 49.7498
- Longitude: 6.1661
- Timezone: Europe/Luxembourg
More informations about "Knight Therapeutics"
Knight Therapeutics - Wikipedia
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange (symbol GUD), with a market capitalization of $1.02 billion as of August 2019. See details»
Knight Therapeutics Inc. (GUD.TO) - Yahoo Finance Canada
Find the latest Knight Therapeutics Inc. (GUD.TO) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Knight Therapeutics Inc. …See details»
Knight Therapeutics Inc. (TSX: GUD) Company Profile & Overview
Oct 8, 2024 Ticker Symbol: GUD: Exchange: Toronto Stock Exchange: Fiscal Year: January - December: Reporting Currency: CAD: ISIN Number: CA4990531069: SIC Code: 2834See details»
Knight Therapeutics Inc. (TSX: GUD) - Stock Analysis
3 days ago MONTREAL, Sept. 27, 2024 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX:GUD) (“Knight” or “the Company”) is pleased to announce it has ranked No. 397 on the …See details»
KNIGHT THERAPEUTICS INC.
Section 1 – About Knight Therapeutics Inc. Knight Therapeutics Inc. is a specialty pharmaceutical company, headquartered in Montreal, Canada, and listed on the Toronto Stock Exchange …See details»
Knight Therapeutics Inc. Celebrates its First Decade of Success
MONTREAL, Feb. 28, 2024 (GLOBE NEWSWIRE) - Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today …See details»
Knight Therapeutics Inc. Celebrates its First Decade of Success
Feb 28, 2024 Knight’s Latin American subsidiaries operate under United Medical, Biotoscana Farma and Laboratorio LKM. Knight Therapeutics Inc.’s shares trade on TSX under the …See details»
Knight Therapeutics Inc (GUD-T) Profile - The Globe and Mail
Knight Therapeutics Inc 3400 De Maisonneuve West Suite 1055 Montreal QC H3Z 3B8 CAN P: 514-484-4483 F: 514-481-4116 https://www.gud-knight.comSee details»
Knight Therapeutics Reports Fourth Quarter and Year-End 2023 …
Mar 21, 2024 Achieved Record Annual Revenues and EBITDA MONTREAL, March 21, 2024 (GLOBE NEWSWIRE) - Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a …See details»
press-release-3 – Knight Therapeutics
MONTREAL, Oct. 02, 2023 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX:GUD) (“Knight” or “the Company”) is pleased to announce it placed No. 90 on the 2023 Report on …See details»
TSX:GUD (Knight Therapeutics Inc.) - The Motley Fool Canada
TSX:GUD (Knight Therapeutics Inc.) About GUD. Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on …See details»
Knight Therapeutics Announces Leadership Change - Yahoo Finance
May 13, 2021 Investor Contact: Knight Therapeutics Inc.Samira SakhiaPresident and Chief Operating OfficerT: 514-484-4483F: [email protected] www.gud …See details»
GUD | Knight Therapeutics Inc. Profile | MarketWatch
Knight Therapeutics Inc. company facts, information and financial ratios from MarketWatch. ... GUD Profile. Company Profile. Knight Therapeutics Inc. 3400 de Maisonneuve West. Suite 1055.See details»
Knight Therapeutics Inc. (GUD.TO) - Yahoo Finance Canada
Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD) MONTREAL, Nov. 14, 2024 (GLOBE NEWSWIRE) -- …See details»
Knight Therapeutics Inc (GUD-T) Stock Price and News
Real-time Price Updates for Knight Therapeutics Inc (GUD-T), along with buy or sell indicators, analysis, charts, historical performance, news and moreSee details»
GUD.TO - Knight Therapeutics Stock Price - Barchart.com
Knight Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.See details»
Knight Therapeutics (GUD) Stock Price, News & Analysis
Nov 24, 2024 In the past three months, Knight Therapeutics insiders have sold 224.53% more of their company's stock than they have bought. Specifically, they have bought C$566,672.00 in …See details»
Knight Therapeutics Inc. places on The Globe and Mail’s
MONTREAL, March 25, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”) is pleased to announce it has been recognized in The Globe and …See details»